CL2017000153A1 - Composiciones de azúcares para la formación de comprimidos mediante compresión directa - Google Patents

Composiciones de azúcares para la formación de comprimidos mediante compresión directa

Info

Publication number
CL2017000153A1
CL2017000153A1 CL2017000153A CL2017000153A CL2017000153A1 CL 2017000153 A1 CL2017000153 A1 CL 2017000153A1 CL 2017000153 A CL2017000153 A CL 2017000153A CL 2017000153 A CL2017000153 A CL 2017000153A CL 2017000153 A1 CL2017000153 A1 CL 2017000153A1
Authority
CL
Chile
Prior art keywords
tabletting
direct compression
sugar compositions
compositions
sugar
Prior art date
Application number
CL2017000153A
Other languages
English (en)
Inventor
Baptiste Boit
Pierre Lanos
Fabrice Buquet
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of CL2017000153A1 publication Critical patent/CL2017000153A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/25—Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<p>LA PRESENTE INVENCIÓN SE REFIERE A COMPOSICIONES DIRECTAMENTE COMPRESIBLES QUE COMPRENDEN MÁS DE 30 % EN PESO DE ALULOSA, Y A COMPRIMIDOS OBTENIBLES A PARTIR DE LAS MISMAS.</p>
CL2017000153A 2014-07-21 2017-01-19 Composiciones de azúcares para la formación de comprimidos mediante compresión directa CL2017000153A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14306181 2014-07-21

Publications (1)

Publication Number Publication Date
CL2017000153A1 true CL2017000153A1 (es) 2017-07-28

Family

ID=51265637

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017000153A CL2017000153A1 (es) 2014-07-21 2017-01-19 Composiciones de azúcares para la formación de comprimidos mediante compresión directa

Country Status (12)

Country Link
US (3) US20170208849A1 (es)
EP (1) EP3171709B1 (es)
JP (1) JP6731400B2 (es)
KR (1) KR102557664B1 (es)
CN (1) CN106659225B (es)
BR (1) BR112017001000B1 (es)
CA (1) CA2955845C (es)
CL (1) CL2017000153A1 (es)
ES (1) ES2991586T3 (es)
MX (1) MX389177B (es)
SG (1) SG11201700445YA (es)
WO (1) WO2016012853A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105148280A (zh) * 2015-07-07 2015-12-16 深圳国源国药有限公司 一种创新药用辅料可压性蔗糖及其制备方法
FR3061413B1 (fr) 2017-01-05 2021-08-27 Roquette Freres Procede de fabrication de cristaux de d-allulose
US10925853B2 (en) * 2019-04-17 2021-02-23 Nordiccan A/S Oral cannabinoid tablet
CN115460932A (zh) * 2020-04-30 2022-12-09 弗门尼舍有限公司 风味剂颗粒、其制备方法以及稳定风味剂的用途
MX2023002740A (es) * 2020-09-07 2023-04-03 Savanna Ingredients Gmbh Proceso de extrusion para la preparacion de una composicion solida de alulosa.
EP4000419A1 (de) 2020-11-23 2022-05-25 Savanna Ingredients GmbH Trocknung von allulosekristallen

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3305447A (en) 1963-06-12 1967-02-21 American Sugar Tabletting sugar and method of preparing same
US3627583A (en) 1969-04-29 1971-12-14 Sucrest Corp Direct compression vehicles
US4698101A (en) * 1982-08-30 1987-10-06 Suomen Sokeri Oy (Finnish Sugar Company Ltd.) Binder-diluent composition and method
FI104787B (fi) * 1989-06-07 2000-04-14 Xyrofin Oy Fruktoosipohjainen rakeistettu tuote ja menetelmä sen valmistamiseksi
EP1175899B1 (fr) 2000-07-27 2007-08-29 Roquette FrÀ¨res Granules à base d'amidon et de lactose
CN1668735A (zh) * 2002-05-22 2005-09-14 国立大学法人香川大学 稀有糖的生物活性的利用方法及配合了稀有糖的组合物
WO2005060937A1 (en) * 2003-12-23 2005-07-07 Chr. Hansen A/S Compressed tablets comprising viable probiotic microorganisms
JP4761424B2 (ja) * 2004-03-17 2011-08-31 株式会社希少糖生産技術研究所 Ｌ−プシコース結晶、その製造方法および、糖試薬キット
EP1757297B1 (en) 2004-05-26 2013-11-13 National University Corporation Kagawa University COMPOSITION FOR treating ARTERIOSCLEROSIS IN DIABETIC PATIENTS
US8071558B2 (en) * 2005-03-23 2011-12-06 Rare Sugar Production Technical Research Laboratories, Llc. Application of D-psicose to suppression of abnormal circadian increase in blood glucose level
JP5116071B2 (ja) * 2005-07-20 2013-01-09 帝國製薬株式会社 Ｄ−アロースおよびｄ−プシコースの抗神経因性疼痛効果の利用
JP4942001B2 (ja) * 2006-11-10 2012-05-30 松谷化学工業株式会社 Ｄ−プシコース含有甘味料およびそれを使用して得られた飲食品など
WO2008059625A1 (fr) 2006-11-17 2008-05-22 National University Corporation Kagawa University Utilisation de la fonction de sucre rare en tant que promoteur de la migration de glucokinase depuis le noyau jusqu'au cytoplasme
WO2008142860A1 (ja) 2007-05-18 2008-11-27 Matsutani Chemical Industry Co., Ltd. 砂糖様味質をもつ新規甘味料、その製造法および用途
FR2925499B1 (fr) * 2007-12-20 2010-02-12 Roquette Freres Maltitol granule pour compression directe et son procede de preparation
JP5859191B2 (ja) * 2010-09-29 2016-02-10 松谷化学工業株式会社 高甘味度甘味料に対する呈味改良組成物およびその応用
JP6216493B2 (ja) * 2011-06-24 2017-10-18 国立大学法人 香川大学 寿命延長剤
CN102697744B (zh) * 2012-05-29 2013-11-27 安吉东来药用辅料有限责任公司 阿洛糖片剂赋形剂、药物片剂及药物片剂的制备方法
KR102303570B1 (ko) 2013-04-26 2021-09-16 마쓰다니가가꾸고오교가부시끼가이샤 에너지 소비의 촉진 및/또는 에너지 소비 기능 저하의 치료 및/또는 예방제, 또는 방법

Also Published As

Publication number Publication date
US20220240560A1 (en) 2022-08-04
US20170208849A1 (en) 2017-07-27
EP3171709C0 (en) 2024-09-04
EP3171709A1 (en) 2017-05-31
BR112017001000A2 (pt) 2017-11-14
MX389177B (es) 2025-03-20
CN106659225A (zh) 2017-05-10
KR102557664B1 (ko) 2023-07-20
US20190090528A1 (en) 2019-03-28
US11986002B2 (en) 2024-05-21
WO2016012853A1 (en) 2016-01-28
EP3171709B1 (en) 2024-09-04
JP6731400B2 (ja) 2020-07-29
MX2017000829A (es) 2017-05-01
BR112017001000B1 (pt) 2021-11-30
ES2991586T3 (es) 2024-12-03
CA2955845C (en) 2022-08-16
CN106659225B (zh) 2021-04-02
JP2017522032A (ja) 2017-08-10
CA2955845A1 (en) 2016-01-28
US11350658B2 (en) 2022-06-07
SG11201700445YA (en) 2017-02-27
KR20170030524A (ko) 2017-03-17

Similar Documents

Publication Publication Date Title
CL2017000136A1 (es) Composiciones de azúcar para la formación de comprimidos por compresión directa
CL2017000153A1 (es) Composiciones de azúcares para la formación de comprimidos mediante compresión directa
MX390064B (es) Formas cristalinas de mononucleotido de beta-nicotinamida.
CU20180001A7 (es) Derivados de oxopiridina sustituidos y procesos para su preparación
UY33735A (es) Compuestos antivirales
EA201691259A1 (ru) РЕГУЛЯТОРЫ Nrf2
CO2018003452A2 (es) Anticuerpos biespecíficos contra el cd20 humano y el receptor de transferrina humano y métodos de uso
MX2017014956A (es) Agonistas de receptor de apelina (apj) de 4-hidroxi-3-(heteroaril) piridin-2-ona como para uso en el tratamiento de trastornos cardiovasculares.
GT201600147A (es) Compuestos derivados y composiciones de n-azaspirocicloalcano n-heteroaril sustituido para inhibir la actividad de shp2
ECSP17064695A (es) Compuestos y composiciones de alfa-cinamida como inhibidores de hdac8
MX367521B (es) Composiciones de insulina de rápida acción.
CO2018001840A2 (es) Composiciones biofarmacéuticas que comprenden anticuerpos anti-il-5
BR112018011526A2 (pt) compostos policíclicos como inibidores da tirosina quinase de bruton
MX2017007377A (es) Compuestos organicos.
DOP2016000212A (es) Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
GT201500247A (es) Imidazopiridazinas sustituidas
PH12017500304A1 (en) Vaccine compositions against dengue virus diseases
MX2017007371A (es) Compuestos antibacterianos que tienen un amplio espectro de actividad.
TN2018000351A1 (en) Oxaborole esters and uses thereof
GT201600252A (es) Derivados de naftiridinadiona
BR112016028192A2 (pt) gerritdina g. schoonus-gerritsma
BR112016023767A2 (pt) forma sólida, composição farmacêutica, compostos, métodos, composições e utilizações
EA201691465A1 (ru) Средство для лечения сердечно-сосудистых заболеваний
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.